Chemicals - Specialty
Build Your Comparison
Side-by-side financial analysisStock Comparison
CMT vs MTRN vs JPM vs BAC vs MP
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial Materials
Banks - Diversified
Banks - Diversified
Industrial Materials
CMT vs MTRN vs JPM vs BAC vs MP — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Chemicals - Specialty | Industrial Materials | Banks - Diversified | Banks - Diversified | Industrial Materials |
| Market Cap | $227M | $5.14B | $896.00B | $422.78B | $10.25B |
| Revenue (TTM) | $271M | $1.92B | $280.33B | $191.57B | $348M |
| Net Income (TTM) | $10M | $76M | $57.05B | $30.51B | $-71M |
| Gross Margin | 17.6% | 15.8% | 60.0% | 56.1% | 24.2% |
| Operating Margin | 4.4% | 6.1% | 25.9% | 19.7% | -39.4% |
| Forward P/E | 23.0x | 38.4x | 14.4x | 12.6x | 247.8x |
| Total Debt | $33M | $601M | $942.38B | $365.90B | $1.04B |
| Cash & Equiv. | $38M | $14M | $343.34B | $231.84B | $1.17B |
CMT vs MTRN vs JPM vs BAC vs MP — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Core Molding Techno… (CMT) | 100 | 598.1 | +498.1% |
| Materion Corporation (MTRN) | 100 | 402.1 | +302.1% |
| JPMorgan Chase & Co. (JPM) | 100 | 341.0 | +241.0% |
| Bank of America Cor… (BAC) | 100 | 235.9 | +135.9% |
| MP Materials Corp. (MP) | 100 | 577.2 | +477.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CMT vs MTRN vs JPM vs BAC vs MP
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CMT ranks third and is worth considering specifically for sleep-well-at-night.
- Lower volatility, beta 0.49, Low D/E 20.8%, current ratio 3.02x
- Beta 0.49 vs MP's 1.91, lower leverage
MTRN is the #2 pick in this set and the best alternative if growth exposure and long-term compounding is your priority.
- Rev growth 6.0%, EPS growth 11.8%, 3Y rev CAGR 0.6%
- 9.0% 10Y total return vs JPM's 465.8%
- +206.9% vs JPM's +21.8%
- 4.2% ROA vs MP's -2.0%, ROIC 6.0% vs -4.7%
JPM carries the broadest edge in this set and is the clearest fit for valuation efficiency and bank quality.
- PEG 0.81 vs CMT's 4.08
- NIM 2.2% vs BAC's 1.8%
- Lower P/E (14.4x vs 247.8x)
- 20.4% margin vs MP's -20.5%
BAC is the clearest fit if your priority is income & stability and defensive.
- Dividend streak 12 yrs, beta 0.86, yield 2.3%
- Beta 0.86, yield 2.3%, current ratio 0.42x
MP is the clearest fit if your priority is growth.
- 35.1% revenue growth vs CMT's -9.5%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 35.1% revenue growth vs CMT's -9.5% | |
| Value | Lower P/E (14.4x vs 247.8x) | |
| Quality / Margins | 20.4% margin vs MP's -20.5% | |
| Stability / Safety | Beta 0.49 vs MP's 1.91, lower leverage | |
| Dividends | 1.9% yield, 15-year raise streak, vs BAC's 2.3%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +206.9% vs JPM's +21.8% | |
| Efficiency (ROA) | 4.2% ROA vs MP's -2.0%, ROIC 6.0% vs -4.7% |
CMT vs MTRN vs JPM vs BAC vs MP — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CMT vs MTRN vs JPM vs BAC vs MP — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
CMT leads in 2 of 6 categories
JPM leads 1 • MTRN leads 1 • BAC leads 0 • MP leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 1034.7x CMT's $271M. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to MP's -20.5%. On growth, MP holds the edge at +118.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $271M | $1.9B | $280.3B | $191.6B | $348M |
| EBITDAEarnings before interest/tax | $21M | $187M | $81.4B | $40.0B | -$27M |
| Net IncomeAfter-tax profit | $10M | $76M | $57.0B | $30.5B | -$71M |
| Free Cash FlowCash after capex | -$15M | $7M | $100.9B | $12.6B | -$314M |
| Gross MarginGross profit ÷ Revenue | +17.6% | +15.8% | +60.0% | +56.1% | +24.2% |
| Operating MarginEBIT ÷ Revenue | +4.4% | +6.1% | +25.9% | +19.7% | -39.4% |
| Net MarginNet income ÷ Revenue | +3.5% | +4.0% | +20.4% | +15.9% | -20.5% |
| FCF MarginFCF ÷ Revenue | -5.7% | +0.4% | +36.0% | +6.6% | -90.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | -4.7% | +30.8% | — | — | +118.6% |
| EPS Growth (YoY)Latest quarter vs prior year | -72.2% | +8.2% | +16.0% | +18.3% | +71.4% |
Valuation Metrics
CMT leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 14.7x trailing earnings, BAC trades at a 79% valuation discount to MTRN's 69.1x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.90x vs CMT's 3.38x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $227M | $5.1B | $896.0B | $422.8B | $10.2B |
| Enterprise ValueMkt cap + debt − cash | $222M | $5.7B | $1.50T | $556.8B | $10.1B |
| Trailing P/EPrice ÷ TTM EPS | 19.10x | 69.07x | 16.00x | 14.66x | -115.10x |
| Forward P/EPrice ÷ next-FY EPS est. | 23.03x | 38.41x | 14.40x | 12.56x | 247.85x |
| PEG RatioP/E ÷ EPS growth rate | 3.38x | 1.88x | 0.90x | 0.95x | — |
| EV / EBITDAEnterprise value multiple | 8.34x | 30.99x | 18.36x | 13.92x | — |
| Price / SalesMarket cap ÷ Revenue | 0.83x | 2.88x | 3.20x | 2.21x | 37.19x |
| Price / BookPrice ÷ Book value/share | 1.35x | 5.48x | 2.47x | 1.39x | 4.09x |
| Price / FCFMarket cap ÷ FCF | 118.29x | 102.94x | 8.88x | 33.52x | — |
Profitability & Efficiency
CMT leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $-3 for MP. CMT carries lower financial leverage with a 0.21x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), BAC scores 7/9 vs MP's 4/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +6.2% | +8.2% | +15.9% | +10.1% | -3.5% |
| ROA (TTM)Return on assets | +4.2% | +4.2% | +1.3% | +0.9% | -2.0% |
| ROICReturn on invested capital | +7.6% | +6.0% | +4.5% | +3.5% | -4.7% |
| ROCEReturn on capital employed | +7.8% | +7.7% | +8.9% | +4.5% | -4.2% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 | 5 | 7 | 4 |
| Debt / EquityFinancial leverage | 0.21x | 0.64x | 2.60x | 1.21x | 0.44x |
| Net DebtTotal debt minus cash | -$5M | $587M | $599.0B | $134.1B | -$123M |
| Cash & Equiv.Liquid assets | $38M | $14M | $343.3B | $231.8B | $1.2B |
| Total DebtShort + long-term debt | $33M | $601M | $942.4B | $365.9B | $1.0B |
| Interest CoverageEBIT ÷ Interest expense | 144.87x | 4.07x | 0.74x | 0.48x | -2.91x |
Total Returns (Dividends Reinvested)
MTRN leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in MTRN five years ago would be worth $32,297 today (with dividends reinvested), compared to $14,715 for BAC. Over the past 12 months, MTRN leads with a +206.9% total return vs JPM's +21.8%. The 3-year compound annual growth rate (CAGR) favors MP at 38.3% vs CMT's 8.7% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +26.6% | +92.6% | -0.5% | +1.1% | +4.7% |
| 1-Year ReturnPast 12 months | +47.7% | +206.9% | +21.8% | +28.1% | +97.1% |
| 3-Year ReturnCumulative with dividends | +28.5% | +130.6% | +138.2% | +103.0% | +164.5% |
| 5-Year ReturnCumulative with dividends | +82.5% | +223.0% | +118.2% | +47.1% | +73.0% |
| 10-Year ReturnCumulative with dividends | +88.8% | +902.8% | +465.8% | +368.2% | +475.5% |
| CAGR (3Y)Annualised 3-year return | +8.7% | +32.1% | +33.6% | +26.6% | +38.3% |
Risk & Volatility
Evenly matched — CMT and BAC each lead in 1 of 2 comparable metrics.
Risk & Volatility
CMT is the less volatile stock with a 0.49 beta — it tends to amplify market swings less than MP's 1.91 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BAC currently trades 97.3% from its 52-week high vs MP's 57.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.49x | 1.84x | 0.94x | 0.86x | 1.91x |
| 52-Week HighHighest price in past year | $28.69 | $257.14 | $337.25 | $57.55 | $100.25 |
| 52-Week LowLowest price in past year | $16.12 | $76.09 | $262.71 | $43.66 | $25.17 |
| % of 52W HighCurrent price vs 52-week peak | +85.9% | +96.2% | +95.1% | +97.3% | +57.4% |
| RSI (14)Momentum oscillator 0–100 | 55.7 | 71.2 | 59.1 | 68.3 | 43.5 |
| Avg Volume (50D)Average daily shares traded | 32K | 252K | 7.0M | 31.7M | 6.0M |
Analyst Outlook
Evenly matched — JPM and BAC each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CMT as "Buy", MTRN as "Buy", JPM as "Buy", BAC as "Buy", MP as "Buy". Consensus price targets imply 44.2% upside for MP (target: $83) vs -34.9% for MTRN (target: $161). For income investors, BAC offers the higher dividend yield at 2.26% vs MTRN's 0.22%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | $24.00 | $161.00 | $339.75 | $61.13 | $83.00 |
| # AnalystsCovering analysts | 2 | 10 | 61 | 54 | 12 |
| Dividend YieldAnnual dividend ÷ price | — | +0.2% | +1.9% | +2.3% | — |
| Dividend StreakConsecutive years of raises | 0 | 13 | 15 | 12 | — |
| Dividend / ShareAnnual DPS | — | $0.55 | $5.95 | $1.27 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +1.4% | +0.2% | +3.9% | +5.1% | 0.0% |
CMT leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). JPM leads in 1 (Income & Cash Flow). 2 tied.
CMT vs MTRN vs JPM vs BAC vs MP: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CMT or MTRN or JPM or BAC or MP a better buy right now?
For growth investors, MP Materials Corp.
(MP) is the stronger pick with 35. 1% revenue growth year-over-year, versus -9. 5% for Core Molding Technologies, Inc. (CMT). Bank of America Corporation (BAC) offers the better valuation at 14. 7x trailing P/E (12. 6x forward), making it the more compelling value choice. Analysts rate Core Molding Technologies, Inc. (CMT) a "Buy" — based on 2 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CMT or MTRN or JPM or BAC or MP?
On trailing P/E, Bank of America Corporation (BAC) is the cheapest at 14.
7x versus Materion Corporation at 69. 1x. On forward P/E, Bank of America Corporation is actually cheaper at 12. 6x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus Core Molding Technologies, Inc. 's 4. 08x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — CMT or MTRN or JPM or BAC or MP?
Over the past 5 years, Materion Corporation (MTRN) delivered a total return of +223.
0%, compared to +47. 1% for Bank of America Corporation (BAC). Over 10 years, the gap is even starker: MTRN returned +902. 8% versus CMT's +88. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CMT or MTRN or JPM or BAC or MP?
By beta (market sensitivity over 5 years), Core Molding Technologies, Inc.
(CMT) is the lower-risk stock at 0. 49β versus MP Materials Corp. 's 1. 91β — meaning MP is approximately 293% more volatile than CMT relative to the S&P 500. On balance sheet safety, Core Molding Technologies, Inc. (CMT) carries a lower debt/equity ratio of 21% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — CMT or MTRN or JPM or BAC or MP?
By revenue growth (latest reported year), MP Materials Corp.
(MP) is pulling ahead at 35. 1% versus -9. 5% for Core Molding Technologies, Inc. (CMT). On earnings-per-share growth, the picture is similar: Materion Corporation grew EPS 1179% year-over-year, compared to -14. 6% for Core Molding Technologies, Inc.. Over a 3-year CAGR, MTRN leads at 0. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CMT or MTRN or JPM or BAC or MP?
JPMorgan Chase & Co.
(JPM) is the more profitable company, earning 20. 4% net margin versus -31. 2% for MP Materials Corp. — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus -44. 6% for MP. At the gross margin level — before operating expenses — JPM leads at 59. 9%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CMT or MTRN or JPM or BAC or MP more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus Core Molding Technologies, Inc. 's 4. 08x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Bank of America Corporation (BAC) trades at 12. 6x forward P/E versus 247. 8x for MP Materials Corp. — 235. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for MP: 44. 2% to $83. 00.
08Which pays a better dividend — CMT or MTRN or JPM or BAC or MP?
In this comparison, BAC (2.
3% yield), JPM (1. 9% yield), MTRN (0. 2% yield) pay a dividend. CMT, MP do not pay a meaningful dividend and should not be held primarily for income.
09Is CMT or MTRN or JPM or BAC or MP better for a retirement portfolio?
For long-horizon retirement investors, Bank of America Corporation (BAC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
86), 2. 3% yield, +368. 2% 10Y return). MP Materials Corp. (MP) carries a higher beta of 1. 91 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BAC: +368. 2%, MP: +475. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CMT and MTRN and JPM and BAC and MP?
These companies operate in different sectors (CMT (Basic Materials) and MTRN (Basic Materials) and JPM (Financial Services) and BAC (Financial Services) and MP (Basic Materials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CMT is a small-cap quality compounder stock; MTRN is a small-cap quality compounder stock; JPM is a large-cap deep-value stock; BAC is a large-cap deep-value stock; MP is a mid-cap high-growth stock. JPM, BAC pay a dividend while CMT, MTRN, MP do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.